131 related articles for article (PubMed ID: 32132653)
1. Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.
Bastos-Oreiro M; Balsalobre P; Miralles P; Berenguer J; Dorado N; Bailen R; Obreoscoa G; Anguita J; Serrano D; Díez-Martín JL; Kwon M
Bone Marrow Transplant; 2020 Sep; 55(9):1716-1725. PubMed ID: 32132653
[TBL] [Abstract][Full Text] [Related]
2. Autologous stem-cell transplantation in patients with HIV-related lymphoma.
Balsalobre P; Díez-Martín JL; Re A; Michieli M; Ribera JM; Canals C; Rosselet A; Conde E; Varela R; Cwynarski K; Gabriel I; Genet P; Guillerm G; Allione B; Ferrant A; Biron P; Espigado I; Serrano D; Sureda A
J Clin Oncol; 2009 May; 27(13):2192-8. PubMed ID: 19332732
[TBL] [Abstract][Full Text] [Related]
3. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.
Díez-Martín JL; Balsalobre P; Re A; Michieli M; Ribera JM; Canals C; Conde E; Rosselet A; Gabriel I; Varela R; Allione B; Cwynarski K; Genet P; Espigado I; Biron P; Schmitz N; Hunter AE; Ferrant A; Guillerm G; Hentrich M; Jurado M; Fernández P; Serrano D; Rossi G; Sureda A;
Blood; 2009 Jun; 113(23):6011-4. PubMed ID: 19307667
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Massoud R; Assi R; Fares E; Haffar B; Charafeddine M; Kreidieh N; Mahfouz R; Kanj SS; El Zakhem A; Kharfan-Dabaja M; Bazarbachi A; El Cheikh J
J Clin Virol; 2017 Oct; 95():36-41. PubMed ID: 28843110
[TBL] [Abstract][Full Text] [Related]
5. Postautologous stem cell transplantation long-term outcomes in 26 HIV-positive patients affected by relapsed/refractory lymphoma.
Zanet E; Taborelli M; Rupolo M; Durante C; Mazzucato M; Zanussi S; De Paoli P; Serraino D; Tirelli U; Lleshi A; Michieli M
AIDS; 2015 Nov; 29(17):2303-8. PubMed ID: 26418085
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.
Davison K; Chen BE; Kukreti V; Couban S; Benger A; Berinstein NL; Kaizer L; Desjardins P; Mangel J; Zhu L; Djurfeldt MS; Hay AE; Shepherd LE; Crump M
Ann Oncol; 2017 Mar; 28(3):622-627. PubMed ID: 27993811
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma.
Ramaswami R; Pria AD; Parker K; McCann S; Kanfer EJ; Nelson M; Bower M
Bone Marrow Transplant; 2016 Dec; 51(12):1609-1611. PubMed ID: 27595283
[No Abstract] [Full Text] [Related]
8. Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma.
Delagreverie HM; Gerard L; Chaillon A; Roelens M; Djerroudi L; Salmona M; Larghero J; Galicier L; Simon F; Oksenhendler E; Moins-Teisserenc H; Delaugerre C
AIDS; 2019 Feb; 33(2):247-257. PubMed ID: 30325771
[TBL] [Abstract][Full Text] [Related]
9. Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected?
Resino S; Pérez A; Seoane E; Serrano D; Berenguer J; Balsalobre P; Goméz-Chacon GF; Díez-Martin JL; Muñoz-Fernández MA
AIDS Res Hum Retroviruses; 2007 Apr; 23(4):543-8. PubMed ID: 17506611
[TBL] [Abstract][Full Text] [Related]
10. Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.
Sun L; Li S; El-Jawahri A; Armand P; Dey BR; Fisher DC; Jacobsen ED; Jacobson CA; LaCasce AS; McAfee SL; Spitzer TR; Chen YB; DeFilipp Z
Oncologist; 2018 May; 23(5):624-630. PubMed ID: 29284757
[TBL] [Abstract][Full Text] [Related]
11. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma.
Simonelli C; Zanussi S; Pratesi C; Rupolo M; Talamini R; Caffau C; Teresa Bortolin M; Tedeschi R; Basaglia G; Mazzucato M; Manuele R; Vaccher E; Spina M; Tirelli U; Michieli M; De Paoli P
Clin Infect Dis; 2010 Jun; 50(12):1672-9. PubMed ID: 20450419
[TBL] [Abstract][Full Text] [Related]
12. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
13. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data.
Yoshinaga N; Kanda J; Aisa Y; Hagiwara S; Mori T; Fukuda T; Ishida Y; Hashimoto H; Iwato K; Kanda Y; Kurokawa M; Nakazawa H; Ota S; Uchida N; Ichinohe T; Atsuta Y; Takaori-Kondo A
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1596-1601. PubMed ID: 29551446
[TBL] [Abstract][Full Text] [Related]
14. Should HIV-positive patients with lymphoma be offered stem cell transplants?
Krishnan A; Zaia J; Forman SJ
Bone Marrow Transplant; 2003 Oct; 32(8):741-8. PubMed ID: 14520416
[TBL] [Abstract][Full Text] [Related]
15. Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?
Marchesi F; Pimpinelli F; Di Domenico EG; Renzi D; Gallo MT; Regazzo G; Rizzo MG; Gumenyuk S; Toma L; Marino M; Cordone I; Cantonetti M; Liberati AM; Montanaro M; Ceribelli A; Prignano G; Palombi F; Romano A; Papa E; Pisani F; Spadea A; Arcese W; Ensoli F; Mengarelli A
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893777
[TBL] [Abstract][Full Text] [Related]
16. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation.
Serrano D; Carrión R; Balsalobre P; Miralles P; Berenguer J; Buño I; Gómez-Pineda A; Ribera JM; Conde E; Díez-Martín JL;
Exp Hematol; 2005 Apr; 33(4):487-94. PubMed ID: 15781340
[TBL] [Abstract][Full Text] [Related]
17. Adequate Engraftment With Lower Hematopoietic Stem Cell Dose.
Jeyaraman P; Borah P; Dayal N; Pathak S; Naithani R
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):260-263. PubMed ID: 32019732
[TBL] [Abstract][Full Text] [Related]
18. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
[TBL] [Abstract][Full Text] [Related]
19. Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation.
Scordo M; Morjaria SM; Littmann ER; Bhatia A; Chung HH; Maloy M; DeAngelis LM; Giralt SA; Taur Y; Sauter CS
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1914-1919. PubMed ID: 29679773
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
